← Leaderboards
George Georgiou Georgiou
University Of Texas At Austin
$8,894,674
Attributed
$13,940,919
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,940,919 · 11
By mechanism
R01$9,588,551 · 6
U01$2,321,423 · 1
R21$852,548 · 2
U19$615,100 · 1
U54$563,297 · 1
Top collaborators
- Everett Stone9 shared
- John Digiovanni5 shared
- Navin Varadarajan5 shared
- Ralph S Baric2 shared
- Jill P Buyon2 shared
- Boris Reizis2 shared
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Everett Stone$5,907,133
- John Digiovanni$26,040,423
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingEngineeringAntibodiesCellsMalignant NeoplasmsResponsePropertyStructureLeadHigh Throughput ScreeningBiochemicalEnzymesProtein EngineeringIn VitroProteinsIn VivoDesignExhibitsPhenotypeAnimal ModelPlasmaCytotoxicMetabolicMouse Model
Grant awards (34)
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$629,341
R01 · FY2025 · AR
Core C - Proteomics Core$255,298
U19 · FY2025 · AI · contact PI
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus$717,625
R01 · FY2024 · AR
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions$461,177
U01 · FY2024 · AI · contact PI
Effective treatment of cystinuria with a novel engineered cyst(e)ine-degrading human enzyme therapy$437,761
R21 · FY2024 · TR · contact PI
Core C - Proteomics Core$359,802
U19 · FY2024 · AI · contact PI
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions$461,591
U01 · FY2023 · AI · contact PI
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions$461,998
U01 · FY2022 · AI · contact PI
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions$462,410
U01 · FY2021 · AI · contact PI
Systematic, molecular level analysis of the Fc receptor ligation on antibody effector functions$474,247
U01 · FY2020 · AI · contact PI
Molecular Analysis of Serum Antibody Constituents in Zika Virus Infection$181,149
R21 · FY2019 · AI · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2018 · CA · contact PI
Molecular Analysis of Serum Antibody Constituents in Zika Virus Infection$233,638
R21 · FY2018 · AI · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2017 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2016 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2015 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2014 · CA · contact PI
Engineering and Evaluation of Human L-Methionase for Cancer Therapy$414,813
R01 · FY2014 · CA · contact PI
Engineering and Evaluation of Human L-Methionase for Cancer Therapy$403,071
R01 · FY2013 · CA · contact PI
Engineering and Evaluation of Human L-Methionase for Cancer Therapy$430,276
R01 · FY2012 · CA · contact PI
Development of antibody-based diagnostic assays for filoviruses$260,820
U54 · FY2012 · AI · contact PI
Engineering and Evaluation of Human L-Methionase for Cancer Therapy$442,512
R01 · FY2011 · CA · contact PI
Human engineered enzymes for L-Arg depletion chemotherapy$330,641
R01 · FY2011 · CA · contact PI
Development of antibody-based diagnostic assays for filoviruses$302,477
U54 · FY2011 · AI · contact PI
Human engineered enzymes for L-Arg depletion chemotherapy$346,306
R01 · FY2010 · CA · contact PI
Human engineered enzymes for L-Arg depletion chemotherapy$312,409
R01 · FY2009 · CA · contact PI
Interconversion of Specificity within Enzyme Families$419,914
R01 · FY2008 · GM · contact PI
Interconversion of Specificity within Enzyme Families$425,366
R01 · FY2007 · GM · contact PI
Genetic Analysis of the Escherichia coli Tat Pathway$226,184
R01 · FY2007 · GM · contact PI
Interconversion of Specificity within Enzyme Families$430,993
R01 · FY2006 · GM · contact PI
Genetic Analysis of the Escherichia coli Tat Pathway$232,939
R01 · FY2006 · GM · contact PI
Interconversion of Specificity within Enzyme Families$446,831
R01 · FY2005 · GM
Genetic Analysis of the Escherichia coli Tat Pathway$238,545
R01 · FY2005 · GM
Genetic Analysis of the Escherichia coli Tat Pathway$238,545
R01 · FY2004 · GM